Clinical trial
Insulin Resistance in Septic Patients in the Acute Phase and After Discharge From Hospital
NCT04969159 is registered in ClinicalTrials.gov with Jens Rikardt Andersen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Insulin Resistance in Septic Patients in the Acute Phase and After Discharge From Hospital
- Lead sponsor
- Jens Rikardt Andersen
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2018
- Completion date
- March 1, 2021
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.